Safety study of a new drug in healthy volunteers
Part of Lungs & breathing clinical trials.
This study tests a new investigational drug called SV001 in healthy volunteers to see if it is safe and how the body handles it. It is a first-in-human trial, meaning this drug has not been tested in people before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 65 years old (implied by Chinese Healthy Adult Volunteers).
- Your weight must be at least 50 kg if male, or 45 kg if female, with a body mass index (BMI) between 19 and 26.
- You cannot have a history of serious drug allergies, drug abuse, or heavy smoking.
- You must not have any significant medical conditions or take other medications that could interfere with the study.
- You agree to use reliable birth control during and for a period after the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new inhaled medicine. You must be a healthy nonsmoker, have normal lung function, and agree to avoid certain medications and foods.
This trial is testing a new drug called SCB0020160 in healthy adult men to see how safe it is and how the body processes it. You take the drug by mouth once or several times.
This trial tests a new drug called SRN001 in healthy men to see how safe it is and how the body processes it. It may help find the right dose for future studies.
This study tests whether a new tablet called SYH2059 can help slow lung scarring in adults with idiopathic pulmonary fibrosis (IPF), a condition where lung tissue becomes thick and stiff over time. You'll take the study drug alongside your current lung treatment to see if it improves your breathing and lung function.
This trial tests a new drug, SB17170, for people with IPF. It aims to see if the drug can help slow down lung damage. You may be eligible if you have a confirmed diagnosis of IPF and meet certain lung function criteria.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.